<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00819208</url>
  </required_header>
  <id_info>
    <org_study_id>CO21</org_study_id>
    <secondary_id>CAN-NCIC-CO21</secondary_id>
    <secondary_id>CDR0000629834</secondary_id>
    <nct_id>NCT00819208</nct_id>
  </id_info>
  <brief_title>Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer</brief_title>
  <official_title>A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canadian Cancer Trials Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Survivorship Research Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Canadian Cancer Trials Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Participating in a physical activity program designed to increase free time
      physical activity and receiving written health education materials may influence the chance
      of cancer recurring as well as impact on physical fitness, psychological well-being and the
      quality of life of patients who have undergone surgery and chemotherapy for colon cancer. It
      is not yet known whether giving a physical activity program together with health education
      materials is more effective than giving health education materials alone for patients who
      have undergone colon cancer treatment.

      PURPOSE: This randomized phase III trial is studying a physical activity program given
      together with health education materials to see how well it works compared with giving health
      education materials alone for patients who have undergone treatment for high-risk stage II or
      stage III colon cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  To compare the disease-free survival (DFS) of medically fit patients who have completed
           surgical resection and adjuvant chemotherapy for high-risk stage II or stage III colon
           cancer when administered a physical activity program with general health education
           materials vs general health education materials alone.

      Secondary

        -  To compare the two intervention arms with respect to overall survival (OS);
           patient-reported outcomes using the SF-36, FACIT-F, PSQI, and HADS questionnaires;
           objective markers of physical fitness using body mass index, hip and waist
           circumference, submaximal exercise testing, and the Seniors' Fitness Test; physical
           activity behavior using the Total Physical Activity Questionnaire (TPAQ); safety profile
           as assessed by NCI CTCAE version 3.0; serum levels of insulin (i.e., IGF-1, IGF-2, and
           IGFBP3); cytokine levels (i.e., IL-1β, IL-6, IL-2, IL-4, IL-8, IL-10, IL-12, TNF-α,
           IFN-γ, and GM-CSF) and C-reactive protein levels; economic evaluations including
           cost-effective and cost-utility analyses; and predictors of physical activity adherence
           using the Social-Cognitive Determinants of Exercise Measure questionnaire.

        -  To evaluate the potential prognostic associations of the serum levels of insulin, IGF-1,
           IGF-2, IGFBP3, blood glucose, cytokines (i.e., IL- 1β, IL-6, IL-2, IL-4, IL-8, IL-10,
           IL-12, TNF-α, IFN-γ, and GM-CSF), and C-reactive protein with DFS, OS, level of physical
           activity, and level of fatigue in these patients.

        -  To evaluate the potential prognostic associations of age, gender, country, incremental
           increase in physical activity, and change in cardiovascular fitness with DFS, OS, level
           of fatigue, and quality of life in these patients.

      OUTLINE: This is a multicenter study. Patients are stratified according to disease stage (II
      vs III), participating center, body mass index (≤ 27.5 vs &gt; 27.5), and ECOG performance
      status (0 vs 1). Patients are randomized to 1 of 2 treatment interventions.

        -  Arm I: Patients receive general health education materials regarding nutrition and
           physical activity and undergo the Colon Health And Life Long Exercise Change (CHALLENGE)
           physical activity program consisting of behavior-support sessions and supervised
           physical activity sessions with a physical activity consultant.

             -  Part I (intensive intervention for 6 months): Patients undergo 12 mandatory
                biweekly face-to-face behavior support sessions combined with 12 mandatory
                supervised physical activity sessions to increase their physical activity goal by
                10 metabolic equivalent task (MET) hours/week. Twelve supervised physical activity
                sessions are also recommended on alternate weeks.

             -  Part II (reduced intervention for months 6-12): Patients undergo 12 mandatory
                biweekly face-to-face or telephone behavior support sessions combined with 12
                recommended supervised physical activity sessions to increase their physical
                activity goal by 20 MET hours/week.

             -  Part III (minimal intervention for months 12-36): Patients undergo mandatory
                monthly face-to-face or telephone behavior support sessions combined with
                recommended supervised physical activity sessions to increase their physical
                activity goal to a maximum total of 27 MET hours/week.

        -  Arm II: Patients receive general health education materials regarding nutrition and
           physical activity.

      Patients complete the Total Physical Activity Questionnaire (TPAQ) to assess exercise
      participation and undergo fitness testing periodically by the submaximal exercise test and
      Seniors' Fitness Test (SFT).

      Patients complete the SF-36, FACT-F, Pittsburgh Sleep Quality Index (PSQI), Hospital Anxiety
      and Depression Scale (HADS), and Social Cognitive Determinants of Exercise Measure
      questionnaires periodically. Patients also complete a 30-day resource use diary and undergo a
      health economics analysis by the Work Productivity and Activity Impairment (WPAI)
      questionnaire.

      Blood samples are collected periodically for correlative studies and fasting glucose. Samples
      are analyzed for markers of insulin level, IGF-1, IGF-2, and IGFBP3, cytokine levels (i.e.,
      IL-1β, IL-6, IL-2, IL-4, IL-8, IL-10, IL-12, TNF-α, IFN-γ, and GM-CSF), and C-reactive
      protein levels.

      During the 3 year intervention period, patients are followed every 6 months for 3 years and
      then annually for 4-10 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 3, 2008</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2029</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported outcomes, including quality of life, using SF-36, FACIT-F, PSQI, and HADS questionnaires</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective markers of physical fitness (i.e., body mass index, hip and waist circumference, cardiovascular fitness, and physical function)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity behavior as assessed by TPAQ</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety profile according to NCI CTCAE version 3.0</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlative biological markers including biochemical and molecular markers associated with insulin-related growth factor and cytokines associated with the mechanisms of fatigue</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic evaluations including cost-effective analysis and cost utility analysis</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictors of physical activity adherence as assessed by Social Cognitive Determinants of Exercise questionnaire</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">962</enrollment>
  <condition>Anxiety Disorder</condition>
  <condition>Cognitive/Functional Effects</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Depression</condition>
  <condition>Fatigue</condition>
  <condition>Psychosocial Effects of Cancer and Its Treatment</condition>
  <condition>Sleep Disorders</condition>
  <condition>Excercise</condition>
  <arm_group>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention Arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Health Education Materials</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control Arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercise intervention</intervention_name>
    <description>3 phases Phase 1: Intensive intervention for 6 months Phase 2: Reduced intervention for months 6-12 Phase 3: Minimal intervention for months 12-36</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>counseling intervention</intervention_name>
    <description>Achieving an increase in PA from baseline of ≥ 10 MET hours/week will require a significant amount of behavioural support. The intervention will comprise a 36-month individualized PA and behavioural support program with a PAC. This will include a personalized PA prescription which takes into account the baseline fitness test results, PA history, performance status and patient's personal PA preferences and any barriers to activity. Most patients are likely to choose a walking program however any PA of at least moderate intensity level is acceptable.</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>educational intervention</intervention_name>
    <description>Once at the beginning of the program</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>laboratory biomarker analysis</intervention_name>
    <description>Every 12 months</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
    <description>Every 6 months</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>study of socioeconomic and demographic variables</intervention_name>
    <description>Every 6 months</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fatigue assessment and management</intervention_name>
    <description>Every 6 months</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
    <description>Every 6 months</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Intervention</intervention_name>
    <description>For Arm 2 just once at beginning of program.</description>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fitness testing</intervention_name>
    <description>Objective fitness testing for both arms</description>
    <arm_group_label>Physical Activity Program + General Health Education Materials</arm_group_label>
    <arm_group_label>General Health Education Materials</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Completely resected histologically confirmed adenocarcinoma of the colon

               -  High-risk stage II disease, including one of the following:

                    -  T4 lesions

                    -  Less than 12 sampled lymph nodes

                    -  Poorly differentiated histology

               -  Stage III disease, defined as having at least one pathologically confirmed
                  positive lymph node or one pathologically confirmed positive tumour deposit.

               -  Synchronous primary colon cancer allowed

          -  Adjuvant chemotherapy treatment for colon cancer with a 5-fluorouracil- based regimen
             received with an intent to provide a complete course of treatment. While one current
             standard is 24 weeks of treatment, patients who are pre-planned to receive a shorter
             duration of chemotherapy, including as part of a research study will also be
             permitted. The actual treatment received may be less than 24 weeks; participants must
             have received a minimum of one treatment cycle.

          -  Chemotherapy must have been completed (i.e. last dose received) a minimum of 60 days
             and a maximum of 180 days prior to registration.

          -  Carcinoembryonic antigen (CEA) ≤ 5 μg/L

          -  Current physical activity levels do not meet the recommended guidelines (≥ 150 minutes
             of moderate-to-vigorous or ≥ 75 minutes of vigorous physical activity/week) as
             calculated using the Leisure Time Exercise Questionnaire (LTEQ)

          -  Completion of chest x-ray or CT, and CT, MRI or ultrasound of abdomen within 60 days
             of registration; these imaging tests must not show evidence of metastatic or
             locally-recurrent colon cancer.

          -  No rectal cancer

        PATIENT CHARACTERISTICS:

          -  ECOG performance status 0-1

          -  Absolute granulocyte count ≥ 1,000/mm³

          -  Platelet count ≥ 100,000/mm³

          -  Hemoglobin ≥ 100 g/L

          -  Serum creatinine ≤ 1.5 times upper limit of normal (ULN)

          -  Total bilirubin ≤ 1.5 times upper limit of normal (ULN)

          -  Alkaline phosphatase &lt; 2.5 times ULN

          -  ALT &lt; 2 times ULN

          -  Not pregnant or planning to become pregnant within the next 3 years

          -  Able (i.e., sufficiently fluent) and willing to effectively communicate with the
             physical activity consultant affiliated with the originating cancer center

          -  Able (i.e., sufficiently fluent in English or French) and willing to complete the
             patient-reported outcome questionnaires, social determinants of exercise measurement,
             health economics, and physical activity questionnaires and logs

          -  Able to complete the baseline exercise test

          -  No significant comorbid conditions precluding participation in a physical activity
             program as determined by the investigator

          -  Likely to participate in a physical activity program, as assessed by the investigator

          -  No history of other malignancies, except adequately treated nonmelanoma skin cancer,
             curatively treated in situ cancer of the cervix, other solid tumors, Hodgkin lymphoma,
             or non-Hodgkin lymphoma curatively treated with no evidence of disease for &gt; 5 years

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics

          -  No prior radiotherapy as a component of treatment for primary tumor

          -  No concurrent treatment with additional chemotherapy or radiation

          -  No concurrent treatment with any medications deemed by the investigator as likely to
             preclude participation in a physical activity program

          -  No concurrent anticancer treatment including chemotherapy, biological, or targeted
             agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kerry Courneya, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Booth, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cancer Centre of Southeastern Ontario at Kingston General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janette Vardy, PhD, FRACP</last_name>
    <role>Study Chair</role>
    <affiliation>Sydney Cancer Centre at Concord Repatriation General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chris O'Callaghan</last_name>
    <phone>613-533-6430</phone>
    <email>cocallaghan@ctg.queensu.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Keteyian</last_name>
      <phone>313-916-9826</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Dickinson Chamberlin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-1651</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Autumn McRee</last_name>
      <phone>919-966-3856</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Armidale Hospital</name>
      <address>
        <city>Armidale</city>
        <state>New South Wales</state>
        <zip>2350</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Pavlakis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bankstown-Lidcombe Hospital</name>
      <address>
        <city>Bankstown</city>
        <state>New South Wales</state>
        <zip>2200</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ray Asghari</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southern Highlands Cancer Centre</name>
      <address>
        <city>Bowral</city>
        <state>New South Wales</state>
        <zip>2576</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Della-Fiorentina</last_name>
      <phone>2 4634-4355</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Horvath</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Coast Cancer Institute Coffs Harbour</name>
      <address>
        <city>Coffs Harbour</city>
        <state>New South Wales</state>
        <zip>2450</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Briscoe</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Concord Repatriation General Hospital</name>
      <address>
        <city>Concord</city>
        <state>New South Wales</state>
        <zip>2139</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Beale</last_name>
      <phone>2 9767-5112</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weng Ng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newcastle Private Hospital</name>
      <address>
        <city>Newcastle</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonino Bonaventura</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Coast Cancer Institute - Port Macquarie</name>
      <address>
        <city>Port Macquarie</city>
        <state>New South Wales</state>
        <zip>2444</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Begbie</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Goldstein</last_name>
      <phone>29 382-2585</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Clarke</last_name>
      <phone>2 9767-5112</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tamworth Hospital</name>
      <address>
        <city>Tamworth</city>
        <state>New South Wales</state>
        <zip>2340</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathew George</last_name>
      <phone>2 6767-7789</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Riverina Cancer Care Centre</name>
      <address>
        <city>Wagga Wagga</city>
        <state>New South Wales</state>
        <zip>2650</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renuka Chittajallu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sydney Adventist Hospital</name>
      <address>
        <city>Wahroonga</city>
        <state>New South Wales</state>
        <zip>2076</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gavin Marx</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew E. Burge</last_name>
      <phone>07 3139-5863</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Euan Walpole</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nimit Singhal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Karapetis</last_name>
      <phone>88 204-4830</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Queen Elizabeth Hospital</name>
      <address>
        <city>Woodville</city>
        <state>South Australia</state>
        <zip>5011</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Price</last_name>
      <phone>618 8222-8429</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ballarat Health Services</name>
      <address>
        <city>Ballarat</city>
        <state>Victoria</state>
        <zip>3353</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bhaumik Shah</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital Melbourne</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Moore</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Ferguson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Macarthur Cancer Therapy Centre - Campbelltown Hospital</name>
      <address>
        <city>Campbelltown</city>
        <zip>2560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aflah Roohullah</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sasha Lupichuk</last_name>
      <phone>403 521-3688</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cross Cancer Institute</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Sun Chua</last_name>
      <phone>780 432-8340</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>BCCA - Vancouver Cancer Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 4E6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Lim</last_name>
      <phone>604 877-6000</phone>
      <phone_ext>672699</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph P.W. Wong</last_name>
      <phone>204 235-3044</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Horizon Health Network</name>
      <address>
        <city>Fredericton</city>
        <state>New Brunswick</state>
        <zip>E3B 5N5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Saleem Raza</last_name>
      <phone>506 447-4095</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Moncton Hospital</name>
      <address>
        <city>Moncton</city>
        <state>New Brunswick</state>
        <zip>E1C 6Z8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Harb</last_name>
      <phone>506 860-2141</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Health Authority B, Zone 2</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony J. Reiman</last_name>
      <phone>506 648-6884</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Juravinski Cancer Centre at Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 5C2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Goffin</last_name>
      <phone>905 387-9495</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kingston Health Sciences Centre</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Booth</last_name>
      <phone>613 549-6666</phone>
      <phone_ext>4505</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grand River Regional Cancer Centre</name>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <zip>N2G 1G3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Hubay</last_name>
      <phone>519 749-4370</phone>
      <phone_ext>5262</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Regional Cancer Program</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sanatani</last_name>
      <phone>519 685-8640</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Credit Valley Hospital</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Myers</last_name>
      <phone>905 813-1100</phone>
      <phone_ext>5135</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stronach Regional Health Centre at Southlake</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 2P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaqil Kassam</last_name>
      <phone>905 895-4521</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital Research Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Jonker</last_name>
      <phone>613 737-7700</phone>
      <phone_ext>70168</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Niagara Health System</name>
      <address>
        <city>St. Catharines</city>
        <state>Ontario</state>
        <zip>L2S 0A9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Findlay</last_name>
      <phone>905 684-7271</phone>
      <phone_ext>43801</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto Rehab</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4G 1R7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika K. Krzyzanowska</last_name>
      <phone>416 946-6542</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odette Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Berry</last_name>
      <phone>416 480-4270</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald L. Burkes</last_name>
      <phone>416 586-5117</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>L'Hotel-Dieu de Levis</name>
      <address>
        <city>Levis</city>
        <state>Quebec</state>
        <zip>G6V 3Z1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Couture</last_name>
      <phone>418 691-5225</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allan Blair Cancer Centre</name>
      <address>
        <city>Regina</city>
        <state>Saskatchewan</state>
        <zip>S4T 7T1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haji Ibrahim Chalchal</last_name>
      <phone>306 766-2691</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saskatoon Cancer Centre</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamal Haider</last_name>
      <phone>306 655-2710</phone>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Montpellier 34298</city>
        <zip>CEDEX 5</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Ychou</last_name>
      <phone>46 761-3066</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Exercise Medicine Center for Diabetes and Cancer</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Jeon</last_name>
      <phone>22 123-6197</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Belfast City Hospital</name>
      <address>
        <city>Belfast</city>
        <state>Co. Antrim</state>
        <zip>BT9 7AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Coyle</last_name>
      <phone>44028 95048492</phone>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>France</country>
    <country>Korea, Republic of</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Courneya KS, Booth CM, Gill S, O'Brien P, Vardy J, Friedenreich CM, Au HJ, Brundage MD, Tu D, Dhillon H, Meyer RM. The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008 Dec;15(6):279-85.</citation>
    <PMID>19079628</PMID>
  </reference>
  <reference>
    <citation>Vallance J, Lesniak SL, Belanger LJ, Courneya KS. Development and assessment of a physical activity guidebook for the Colon Health and Life-Long Exercise Change (CHALLENGE) trial (NCIC CO.21). J Phys Act Health. 2010 Nov;7(6):794-801.</citation>
    <PMID>21088311</PMID>
  </reference>
  <results_reference>
    <citation>Courneya KS, Vardy JL, O'Callaghan CJ, Friedenreich CM, Campbell KL, Prapavessis H, Crawford JJ, O'Brien P, Dhillon HM, Jonker DJ, Chua NS, Lupichuk S, Sanatani MS, Gill S, Meyer RM, Begbie S, Bonaventura T, Burge ME, Turner J, Tu D, Booth CM. Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial. Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):969-77. doi: 10.1158/1055-9965.EPI-15-1267. Epub 2016 Apr 8.</citation>
    <PMID>27197271</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2009</study_first_submitted>
  <study_first_submitted_qc>January 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2009</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fatigue</keyword>
  <keyword>sleep disorders</keyword>
  <keyword>depression</keyword>
  <keyword>anxiety disorder</keyword>
  <keyword>psychosocial effects of cancer and its treatment</keyword>
  <keyword>cognitive/functional effects</keyword>
  <keyword>stage II colon cancer</keyword>
  <keyword>stage III colon cancer</keyword>
  <keyword>adenocarcinoma of the colon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

